Cameron Myhrvold, PhD

2011 Hertz Fellow

Find me on LinkedIn

Cameron Myhrvold is an Assistant Professor of Molecular Biology at Princeton University.

His work specializes in the development of CRISPR-based technologies for studying RNA, with an emphasis on detecting and destroying RNA viruses. He received a PhD in Systems Biology from Harvard in 2016. His PhD studies in synthetic biology and nucleic acid nanotechnology, supported by a Fannie and John Hertz Foundation fellowship, involved the development of three technologies that demonstrated a variety of applications for self-assembled nanostructures. During his postdoc, he turned his attention towards the RNA-targeting CRISPR effector protein Cas13, where he has led or co-led the development of four Cas13-based technologies, including CARMEN, CARVER, and SHINE.

Graduate Studies

Harvard University

Field of Study: Molecular Biology

Thesis: Synthetic Organization in Vitro and in Vivo

Undergraduate Studies

Princeton University

Awards

2018, Forbes “30 Under 30: Science”, Forbes

Related News

Nov 30, 2022

Nathan Myhrvold: Reflections on a Transformational Gift

Hertz Fellow Nathan Myhrvold, visionary technology and business leader, reflects on the anonymous $5 million gift that will fund a Hertz Fellowship in his honor.

Jul 20, 2021

Behind the COVID-19 Diagnostic for Testing Hundreds of People at a Time

The story of the scientists working to get a COVID-19 diagnostic for testing hundreds of people at a time approved in the clinic and the research that started long before the pandemic.

Nov 12, 2020

Hertz Foundation Entrepreneurship Award to Support Microbial Innovation

Cheri Ackerman, CEO and cofounder of Concerto Biosciences, will use the prize to help her company find solutions for human health and agriculture using unique ensembles of microbes.

Aug 10, 2020

Hertz Fellows Join Fight Against COVID-19

During the Hertz Foundation’s 2020 Summer Workshop, Hertz Fellows came together to shed light on the effects of COVID-19 on the nation's healthcare system and discuss new solutions that could offer up some relief amidst the throes of the global pandemic.

Apr 29, 2020

CRISPR-based diagnostic chips perform thousands of tests simultaneously to detect viruses

Hertz Fellows Cheri Ackerman and Cameron Myhrvold's technology can perform thousands of tests simultaneously to detect viruses and return same-day results, with enormous potential for public health impact.

Nov 13, 2018

Three Fellows Win 2019 Forbes “30 Under 30” Honors

Forbes’ 2019 “30 Under 30” list includes three Hertz Fellows leading the way in healthcare innovation: Megan Blewett, Kyle Loh and Cameron Myhrvold.

Apr 30, 2018

Using CRISPR to fight epidemics

Hertz Fellow Cameron Myhrvold leads a study bringing a cutting-edge diagnostic technique into the field.

Apr 7, 2017

Scientists Invent New Method for Improving DNA Nanotechnology Designs

Hertz Fellows Cameron Myhrvold and Michael Baym Invent New Method for Improving DNA Nanotechnology Designs.

Dec 21, 2015

Gut Reactions: Hertz Fellow Cameron Myhrvold Examines Life Cycle of Cells in the Digestive System

Hertz Fellow Cameron Myhrvold, who, along with his colleagues, has devised a new method for measuring the growth rate of gut microbes called distributed cell division counting (DCDC). Potentially, the science could help researchers understand the structure of DNA itself, "mark" cells, and better control which enzymes are expressed. Perhaps most importantly, Myhrvold said, the technology could be used to program the behavior of T-cells, encouraging the immune system to attack only cancer cells, for example, instead of healthy cells.